(3R)-N-(tert-Butoxycarbonyl)-3-amino-4-(2,4,5-trifluorophenyl)butanoic acid, 98%

: (βR)-β-[[(1,1-Dimethylethoxy)carbonyl]amino]-2,4,5-trifluoro-benzenebutanoic Acid; 3R)-3-[(1,1-Dimethylethoxycarbonyl)amino]-4-(2,4,5-trifluorophenyl)butanoic Acid; (3R)-3-[(tert-Butoxycarbonyl)amino]-4-(2,4,5-trifluorophenyl)butanoic Acid; (3R)-3-[N-(tert-Butoxycarbonyl)amino]-4-(2,4,5-trifluorophenyl)butanoic Acid; (R)-3-(((tert-Butoxy)carbonyl)amino)-4-(2,4,5-trifluorophenyl)butyric Acid; (R)-3-[(tert-Butyloxycarbonyl)amino]-4-(2,4,5-trifluorophenyl)butanoic Acid;(R)-N-Boc-3-Amino-4-(2,4,5-trifluorophenyl)butanoicacid

: B 3607

: 486460-00-8

: C₁₅H₁₈F₃NO₄

: 333.3

: B 3607 (OTTO) (3R)-N-(tert-Butoxycarbonyl)-3-amino-4-(2,4,5-trifluorophenyl)butanoic acid, 98% Cas 486460-00-8 - used as a reactant for the preparation of dipeptidyl peptidase-4 (DPP4) inhibitors for the treatment of type 2 diabetes, such as sitagliptin.